These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1703763)

  • 41. Distribution of substance P binding sites in guinea-pig heart and pharmacological effects of substance P.
    Hoover DB; Hancock JC
    J Auton Nerv Syst; 1988 Sep; 23(3):189-97. PubMed ID: 2461407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Visualization of rat brain receptors for the neuropeptide, substance P.
    Rothman RB; Herkenham M; Pert CB; Liang T; Cascieri MA
    Brain Res; 1984 Aug; 309(1):47-54. PubMed ID: 6207890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tachykinin receptor cross-talk. Immunological cross-reactivity between the external domains of the substance K and substance P receptors.
    Parnet P; Mitsuhashi M; Turck CW; Kerdelhue B; Payan DG
    Brain Behav Immun; 1991 Mar; 5(1):73-83. PubMed ID: 1712653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photoaffinity labeling the substance P receptor using a derivative of substance P containing p-benzoylphenylalanine.
    Boyd ND; White CF; Cerpa R; Kaiser ET; Leeman SE
    Biochemistry; 1991 Jan; 30(2):336-42. PubMed ID: 1703017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological in vitro evaluation of new substance P-cyclodextrin derivatives designed to drug targeting towards NK1-receptor bearing cells.
    Péan C; Wijkhuisen A; Djedaïni-Pilard F; Fischer J; Doly S; Conrath M; Couraud JY; Grassi J; Perly B; Créminon C
    Biochim Biophys Acta; 2001 Dec; 1541(3):150-60. PubMed ID: 11755209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and characterization of substance P receptors on LRM55 glial cells.
    Perrone MH; Lepore RD; Shain W
    J Pharmacol Exp Ther; 1986 Aug; 238(2):389-95. PubMed ID: 2426440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoradiographic localization of substance P binding sites in guinea-pig airways.
    Hoover DB; Hancock JC
    J Auton Nerv Syst; 1987 May; 19(2):171-4. PubMed ID: 3036927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific binding of [3H]substance P to the rat submaxillary gland. The effects of ions and guanine nucleotides.
    Bahouth SW; Musacchio JM
    J Pharmacol Exp Ther; 1985 Aug; 234(2):326-36. PubMed ID: 2410593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Passive immunization with an anti-substance P antibody prevents substance P- and neurokinin A-induced bronchospasm in anesthetized guinea-pigs.
    Jafarian A; Suresh MR; Kreutz FT; Biggs DF
    Life Sci; 1995; 57(2):143-53. PubMed ID: 7541500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Substance P antagonists showing some selectivity for different receptor types.
    Regoli D; Mizrahi J; D'Orléans-Juste P; Dion S; Drapeau G; Escher E
    Eur J Pharmacol; 1985 Feb; 109(1):121-5. PubMed ID: 2581793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of DNA immunization to produce polyclonal antibodies against the native human neurokinin-1 receptor for substance P.
    Tymciu S; Wijkhuisen A; Sagot MA; Frobert Y; Grassi J; Créminon C; Couraud JY; Boquet D
    J Neuroimmunol; 2002 Jul; 128(1-2):23-30. PubMed ID: 12098507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-morphine anti-idiotypic antibodies. Opiate receptor binding and isolated tissue responses.
    Ng DS; Isom GE
    Biochem Pharmacol; 1985 Aug; 34(16):2853-8. PubMed ID: 2992520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulation of neurokinin-1 receptor expression in rat spinal cord by an N-terminal metabolite of substance P.
    Velázquez RA; McCarson KE; Cai Y; Kovács KJ; Shi Q; Evensjö M; Larson AA
    Eur J Neurosci; 2002 Jul; 16(2):229-41. PubMed ID: 12169105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stereospecificity of SP1 and SP2 substance P receptors.
    Piercey MF; Dobry-Schreur PJ; Masiques N; Schroeder LA
    Life Sci; 1985 Feb; 36(8):777-80. PubMed ID: 2579310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration.
    Heng YJ; Saunders CI; Kunde DA; Geraghty DP
    Regul Pept; 2011 Apr; 167(2-3):250-8. PubMed ID: 21329730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
    Garret C; Carruette A; Fardin V; Moussaoui S; Peyronel JF; Blanchard JC; Laduron PM
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10208-12. PubMed ID: 1719549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preincubation with substance P induces substance P-stimulated phosphatidylinositol turnover in cultured cerebellar astrocytes.
    Marriott DR; Wilkin GP
    J Neurochem; 1992 Aug; 59(2):443-8. PubMed ID: 1378486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor.
    Lew R; Geraghty DP; Drapeau G; Regoli D; Burcher E
    Eur J Pharmacol; 1990 Aug; 184(1):97-108. PubMed ID: 1698645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
    Gitter BD; Bruns RF; Howbert JJ; Waters DC; Threlkeld PG; Cox LM; Nixon JA; Lobb KL; Mason NR; Stengel PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):737-44. PubMed ID: 7473161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.